Isomark, LLC

Madison, WI 53711

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $2.22MM
First Award Date 09/15/12
Most Recent Award Date 01/01/16

Key Personnel

Last Name Name Awards Contact
Butz Daniel E Butz 5
Pillers De-Ann M Pillers 2

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 01/01/16 - 12/31/16

DESCRIPTION: Infections are a leading cause of mortality in adult and pediatric ICUs. Earlier diagnosis and treatment of infection could significantly reduce patient morbidity and mortality. Unfortunately, current methods of detection cannot routinely detect infection early in the disease course. Isomark has developed a breath-based early detect...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 01/01/15 - 12/31/15

DESCRIPTION: Infections are a leading cause of mortality in adult and pediatric ICUs. Earlier diagnosis and treatment of infection could significantly reduce patient morbidity and mortality. Unfortunately, current methods of detection cannot routinely detect infection early in the disease course. Isomark has developed a breath-based early detect...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 09/01/14 - 02/28/15

DESCRIPTION: Infections are a leading cause of mortality in adult and pediatric ICUs. Earlier diagnosis and treatment of infection could significantly reduce patient morbidity and mortality. Unfortunately, current methods of detection cannot routinely detect infection early in the disease course. Isomark has developed a breath-based early detect...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-HD-12-192
Budget: 09/01/13 - 08/31/14

DESCRIPTION (provided by applicant): Isomark LLC has developed a breath-based early detection technology (comprised of biomarkers and instruments for detection) that can pinpoint the onset of acute systemic inflammation. Isomark's breath biomarkers may provide an indicator of neonatal health. This technology will 1) improve neonatal care outcome...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: RFA-HD-12-192
Budget: 09/15/12 - 08/31/13

DESCRIPTION (provided by applicant): Isomark LLC has developed a breath-based early detection technology (comprised of biomarkers and instruments for detection) that can pinpoint the onset of acute systemic inflammation. Isomark's breath biomarkers may provide an indicator of neonatal health. This technology will 1) improve neonatal care outcome...